During the past decade, Orthopaedic Institute for Children conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 2 clinical trials were completed, i.e. on average, 22.2% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Orthopaedic Institute for Children" #1 sponsor was "University of California, Los Angeles" with 5 trials, followed by "American Thrombosis and Hemostasis Network" with 1 trials sponsored, "Hoffmann-La Roche" with 1 trials sponsored, "Spark Therapeutics" with 1 trials sponsored and "Ultragenyx Pharmaceutical Inc" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Orthopaedic Institute for Children" #1 collaborator was "LFB USA, Inc." with 1 trials as a collaborator, "Northwestern University" with 1 trials as a collaborator and "Project Malawi" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Orthopaedic Institute for Children" are "Adeno-Associated Virus (AAV)" (1 trials), "Blood Coagulation Disorder" (1 trials), "Blood Coagulation Disorders, Inherited" (1 trials), "Cerebral Palsy" (1 trials) and "Coagulation Protein Disorders" (1 trials). Many other conditions were trialed in "Orthopaedic Institute for Children" in a lesser frequency.

Most popular intervention types in "Orthopaedic Institute for Children" are "Drug" (5 trials), "Device" (2 trials), "Genetic" (2 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Acetaminophen" (1 trials), "Axillary Crutches" (1 trials), "DTX101" (1 trials), "Emicizumab" (1 trials) and "Ibuprofen" (1 trials). Other intervention names were less common.

The vast majority of trials in "Orthopaedic Institute for Children" are 7 trials for "All" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Orthopaedic Institute for Children". undefined are not yet recruiting, 5 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Orthopaedic Institute for Children, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Orthopaedic Institute for Children, 2 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 5 trials, and there were also 2 trials that are defined as “Not Applicable".

Orthopaedic Institute for Children has several departments that took part in Clinical trials: "Orthopaedic Hemophilia Treatment Center" - 7 trials